🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit ◆ The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition ◆ The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit ◆ The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition ◆ The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 08 Jul 2026 · ClinicalTrials.gov

Clinical Trials in Indiana

← All US trials

The most recently updated industry-sponsored clinical trials recruiting across the United States — searchable by condition, sponsor, phase and state. Refreshed daily from the ClinicalTrials.gov registry.

29
Recruiting now
37
Studies tracked
Indiana
Selected state
Recruiting Phase 2
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Type 2 Diabetes
Eli Lilly and Company · started 2025-03-28
📍 Arizona · California · Florida · Georgia · Idaho · Indiana · New Jersey · New York
NCT06897475 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
Janssen Research & Development, LLC · started 2013-09-09
📍 California · Connecticut · Georgia · Illinois · Indiana · Kansas · Kentucky · Massachusetts
NCT01804686 on ClinicalTrials.gov ↗
Recruiting Phase 2
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Solid Tumours
Boehringer Ingelheim · started 2024-10-11
📍 Alaska · Arizona · California · Connecticut · Florida · Illinois · Indiana · Maryland
NCT06581432 on ClinicalTrials.gov ↗
Recruiting Phase 3
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Bipolar Depression
Intra-Cellular Therapies, Inc. · started 2024-05-14
📍 Alabama · Arkansas · California · Colorado · Florida · Georgia · Illinois · Indiana
NCT06372964 on ClinicalTrials.gov ↗
Active Phase 3
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC · started 2024-04-09
📍 Arkansas · California · Colorado · Florida · Illinois · Indiana · Kansas · Michigan
NCT06211764 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm
Eli Lilly and Company · started 2024-07-01
📍 California · Colorado · Florida · Illinois · Indiana · Massachusetts · Michigan · Missouri
NCT06465069 on ClinicalTrials.gov ↗
Active Phase 2
A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Prostatic Neoplasms, Castration-Resistant
Janssen Research & Development, LLC · started 2018-03-02
📍 Arizona · Colorado · Florida · Indiana · Maryland · Michigan · New York · Pennsylvania
NCT03431350 on ClinicalTrials.gov ↗
Active Phase 2
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Prostatic Cancer, Castration-Resistant
Novartis Pharmaceuticals · started 2025-07-03
📍 California · Colorado · Connecticut · Indiana · Massachusetts · Nebraska · New York · Pennsylvania
NCT07047118 on ClinicalTrials.gov ↗
Recruiting
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
Aortic Dissection
W.L.Gore & Associates · started 2025-09-22
📍 Alabama · California · Florida · Georgia · Illinois · Indiana · Massachusetts · Michigan
NCT06827990 on ClinicalTrials.gov ↗
Recruiting Phase 2
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
Eli Lilly and Company · started 2026-03-26
📍 Arizona · California · Colorado · Connecticut · Florida · Idaho · Illinois · Indiana
NCT07415044 on ClinicalTrials.gov ↗
Active Phase 2
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Janssen Research & Development, LLC · started 2022-09-19
📍 California · Colorado · Connecticut · District of Columbia · Florida · Georgia · Idaho · Indiana
NCT05242484 on ClinicalTrials.gov ↗
Recruiting Phase 3
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Peripheral Arterial Disease
Eli Lilly and Company · started 2025-10-31
📍 Alabama · Arizona · California · Florida · Indiana · Maryland · Michigan · Pennsylvania
NCT07223593 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Obesity, Weight Gain
Eli Lilly and Company · started 2024-06-03
📍 California · Delaware · Idaho · Illinois · Indiana · New York · Texas · Utah
NCT06439277 on ClinicalTrials.gov ↗
Recruiting Phase 4
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Colorectal Cancer
Takeda · started 2025-01-14
📍 Alabama · Arizona · California · Delaware · Florida · Georgia · Illinois · Indiana
NCT06562543 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Eli Lilly and Company · started 2025-11-28
📍 California · Colorado · Florida · Georgia · Illinois · Indiana · Mississippi · New York
NCT07169851 on ClinicalTrials.gov ↗
Recruiting Phase 3
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Glioblastoma, Recurrent Glioblastoma, GBM
CarThera · started 2024-01-29
📍 Arizona · California · Colorado · Florida · Georgia · Illinois · Indiana · Maryland
NCT05902169 on ClinicalTrials.gov ↗
Active Phase 3
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients
Advanced Ovarian Cancer
AstraZeneca · started 2019-01-04
📍 California · Florida · Georgia · Illinois · Indiana · Maryland · Michigan · Missouri
NCT03737643 on ClinicalTrials.gov ↗
Recruiting Phase 3
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ulcerative Colitis, Obesity or Overweight
Eli Lilly and Company · started 2025-06-26
📍 Alabama · California · Florida · Idaho · Illinois · Indiana · Kentucky · Louisiana
NCT06937086 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma (PDAC)
Revolution Medicines, Inc. · started 2025-12-15
📍 California · Colorado · Connecticut · Florida · Georgia · Indiana · Kansas · Maryland
NCT07252232 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
Adenocarcinoma, Pancreatic Ductal
Genentech, Inc. · started 2023-10-18
📍 California · Connecticut · Illinois · Indiana · Kentucky · Massachusetts · Michigan · Nebraska
NCT05968326 on ClinicalTrials.gov ↗
Recruiting Phase 3
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Crohn's Disease, Obesity or Overweight
Eli Lilly and Company · started 2025-06-26
📍 Alabama · California · Florida · Idaho · Illinois · Indiana · Kentucky · Louisiana
NCT06937099 on ClinicalTrials.gov ↗
Recruiting
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Parkinson's Disease
Boston Scientific Corporation · started 2014-03-04
📍 California · Colorado · Florida · Idaho · Illinois · Indiana · Massachusetts · Missouri
NCT02071134 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Depressive Disorder, Major
Eli Lilly and Company · started 2026-02-09
📍 California · Connecticut · Florida · Georgia · Indiana · Iowa · Maryland · Massachusetts
NCT07412756 on ClinicalTrials.gov ↗
Active Phase 3
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)
PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC
Genmab · started 2024-11-25
📍 Arizona · California · Florida · Georgia · Hawaii · Illinois · Indiana · Kentucky
NCT06635824 on ClinicalTrials.gov ↗
Recruiting Phase 2
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Type 1 Diabetes Mellitus
Mannkind Corporation · started 2026-02-04
📍 California · Colorado · Connecticut · Florida · Indiana · Massachusetts · Oklahoma · Texas
NCT07224321 on ClinicalTrials.gov ↗
Recruiting Phase 2
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
Low Grade Upper Tract Urothelial Carcinoma
Tyra Biosciences, Inc · started 2025-12-22
📍 Georgia · Illinois · Indiana · Massachusetts · New Jersey · New York · Ohio · Tennessee
NCT07265947 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Brenipatide in Participants With Opioid Use Disorder
Opioid Use Disorder
Eli Lilly and Company · started 2026-02-13
📍 Arizona · Arkansas · California · Florida · Illinois · Indiana · Kentucky · Maryland
NCT07420283 on ClinicalTrials.gov ↗
Recruiting Phase 3
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Intra-Cellular Therapies, Inc. · started 2024-12-06
📍 Arkansas · California · Connecticut · Florida · Georgia · Illinois · Indiana · Louisiana
NCT06706674 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Hemophilia A
Hoffmann-La Roche · started 2026-04-27
📍 California · Indiana · Iowa · Washington
NCT07416604 on ClinicalTrials.gov ↗
Recruiting Phase 3
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder
Intra-Cellular Therapies, Inc. · started 2024-01-25
📍 Arizona · Arkansas · California · Colorado · Florida · Georgia · Illinois · Indiana
NCT06229210 on ClinicalTrials.gov ↗
Active Phase 3
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Janssen Research & Development, LLC · started 2024-02-01
📍 Arizona · Arkansas · California · Florida · Georgia · Illinois · Indiana · Kentucky
NCT06143878 on ClinicalTrials.gov ↗
Recruiting Phase 3
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Growth Hormone Deficiency (GHD)
Lumos Pharma · started 2026-05-20
📍 Alabama · California · Colorado · District of Columbia · Florida · Indiana · Iowa · Louisiana
NCT06948214 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Irritable Bowel Syndrome, Constipation
Eli Lilly and Company · started 2026-04-29
📍 Arizona · California · Florida · Illinois · Indiana · Kentucky · New York · Ohio
NCT07545772 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Alzheimer Disease, Dementia, Plaque, Amyloid
Eli Lilly and Company · started 2026-05-22
📍 Arizona · California · Florida · Georgia · Idaho · Illinois · Indiana · Iowa
NCT07602582 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Follicular Lymphoma (FL)
Genmab · started 2024-02-05
📍 California · Colorado · Delaware · Florida · Idaho · Illinois · Indiana · Iowa
NCT06191744 on ClinicalTrials.gov ↗
Active Phase 2
A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
Eli Lilly and Company · started 2023-10-23
📍 Arizona · Arkansas · California · Connecticut · Florida · Georgia · Illinois · Indiana
NCT06046729 on ClinicalTrials.gov ↗
Recruiting
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Bayer · started 2020-04-03
📍 Arizona · California · Colorado · Connecticut · Florida · Indiana · Kansas · Maine
NCT04142437 on ClinicalTrials.gov ↗
No trials match your search.

Browse by state

California · 125 Florida · 104 Georgia · 66 Illinois · 58 Arizona · 57 Colorado · 55 Connecticut · 41 Michigan · 38 Indiana · 37 Alabama · 37 Massachusetts · 36 Texas · 35 New York · 32 Maryland · 27 Ohio · 24 Arkansas · 22

Browse by condition

Obesity · 7 Overweight · 6 Advanced Solid Tumors · 5 Neoplasm Metastasis · 4 Colitis, Ulcerative · 4 Melanoma · 3 Non-small Cell Lung Cancer · 3 Alzheimer Disease · 3 Crohn Disease · 3 Schizophrenia · 3 Small Lymphocytic Lymphoma · 2 Follicular Lymphoma · 2 Osteoarthritis · 2 Overweight or Obesity · 2 Alzheimers Disease · 2 Diabetes Mellitus, Type 1 · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the USA Tracker. Available at: https://priyalifescience.com/clinical-trials-usa/state/indiana (Accessed: 8 July 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one US site, most recently updated first, refreshed daily. This is a curated slice of the full registry, not every US trial. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish and EU sites, see our Ireland and EU trackers.